_PRIVATE_LIMITED.webp)
Pharmaveda (India) Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 25-06-2024
- Paid Up Capital ₹ 1.42 Cr
as on 25-06-2024
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.10 Cr
as on 25-06-2024
- Satisfied Charges ₹ 8.37 Cr
as on 25-06-2024
- Revenue 171.70%
(FY 2022)
- Profit 1054.52%
(FY 2022)
- Ebitda 222.87%
(FY 2022)
- Net Worth 54.67%
(FY 2022)
- Total Assets -20.31%
(FY 2022)
About Pharmaveda (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.42 Cr.
The company currently has active open charges totaling ₹8.10 Cr. The company has closed loans amounting to ₹8.37 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vilas Tungare, Shefali Tungare, Sagar Tungare, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239MH2001PTC131460
- Company No.
131460
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pharmaveda (India)?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amita Vaidya  | Director | 02-Apr-2001 | Current |
| Vilas Tungare | Director | 02-Apr-2001 | Current |
| Shefali Tungare | Director | 08-Apr-2013 | Current |
| Sagar Tungare | Director | 02-Apr-2001 | Current |
| Satish Vaidya | Director | 02-Apr-2001 | Current |
Financial Performance of Pharmaveda (India).
Pharmaveda (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 171.7% increase. The company also saw a substantial improvement in profitability, with a 1054.52% increase in profit. The company's net worth Soared by an impressive increase of 54.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaveda (India)?
In 2022, Pharmaveda (India) had a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bodyblend Wellness Private LimitedActive 2 years 3 monthsShefali Tungare, Sagar Tungare and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Jun 2023 | ₹3.72 M | Open |
Others Creation Date: 11 Apr 2018 | ₹7.73 Cr | Open |
Bank Of Maharashtra Creation Date: 24 Mar 2012 | ₹3.80 M | Satisfied |
How Many Employees Work at Pharmaveda (India)?
Pharmaveda (India) has a workforce of 7 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaveda (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaveda (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
